This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Icon Group's Australian cancer clinic deals raise competition concerns

( June 6, 2024, 04:23 GMT | Official Statement) -- MLex Summary: Icon Group’s proposed string of cancer clinic acquisitions may inhibit access to radiation oncology services in several Australian markets, the competition watchdog has said. In a statement today, the Australian Competition & Consumer Commission said it was concerned Icon’s proposed lease acquisitions could entrench its already strong market position, and increase its ability to raise prices or reduce service levels in South-East Queensland and Geelong. Another key issue was the role of economies of scale in the provision of oncology services, the watchdog said.The statement from the Australian Competition & Consumer Commission follows. The ACCC's Statement of Issues is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections